Erin E. Mulvihill

GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice

Naim Panjwani, Erin E. Mulvihill, Christine Longuet et al. · Endocrinology · 2012 · 346 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

GLP-1 Receptor Expression Within the Human Heart

Laurie L. Baggio, Bernardo Yusta, Erin E. Mulvihill et al. · Endocrinology · 2018 · 301 citations · Full text

Life Sciences, Cardiology, Endocrinology +16

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Emma M. Allister, Brian G. Sutherland et al. · Diabetes · 2009 · 292 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Julia M. Assini, Justin K. Lee et al. · Diabetes · 2011 · 204 citations · Full text

Life Sciences, Endocrinology, Pharmacology +15

Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice

Erin E. Mulvihill, Julia M. Assini, Brian G. Sutherland et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 163 citations

Life Sciences, Nutritional Sciences, Pharmacology +17